Abstract
The Akt1/GSK-3β signaling pathway is involved in the regulation of biological processes in nerve cells. Here we studied the intracellular proteins Akt1 and GSK-3β and their phosphoforms in patients with affective disorders. Sixty patients with diagnoses of depressive episodes, major depressive disorder, and bipolar affective disorder (BAD) and 34 mentally and somatically healthy subjects were examined. Proteins of the Akt1/GSK-3β signaling pathway (total glycogen synthase kinase 3β (GSK-3β), phospho-serine-9-GSK-3β, total protein kinase Akt1, phospho-serine-473-Akt1) were measured in peripheral blood mononuclear cells using the immunoblotting technique. High levels of total GSK-3β were found in groups of patients with affective disorders. Patients with recurrent depressive disorder had an increased level of total GSK-3β as compared with the level in depressive episode. The level of total Akt1 in patients decreased as compared with the control group. Patients with depressive disorder had decreased levels of phospho-serine-473-Akt1. Our results confirm the hypothesis of the involvement of glycogen synthase kinase-3β in the pathogenesis of affective disorders.
Similar content being viewed by others
References
Untsun, T.B. and Sartorius, N., Mental Illness in General Health Care: An International Study. John Wiley and Sons, 1995, p. 398.
Krasnov, V.N., Rasstroistva affektivnogo spektra (Affective disorders), Moscow: Prakticheskaya meditsina, 2011.
Tiganov, A.S., Kopeiko, G.I., Brusov, O.S., and Klyushnik, T.P., Zh. Nevrol. Psikhiatr. Im. S.S. Korsakova, 2012, vol. 112, no. 11, pp. 65–72.
Vyalova, N.M., Fedorenko, O.Yu., Losenkov, I.S., Simutkin, G.G., Ivanova, S.A., and Bokhan, N.A., Fundamental Research, 2013, no. 12, part 1, pp. 107–110.
Losenkov, I.S., Vyalova, N.M., Simutkin, G.G., Ivanova, S.A., and Bokhan, N.A., Sovr. Probl. Nauki i Obrazov., 2013, no. 6, http://www.science-education.ru/113-11027.
Fedorenko, O., Strutz-Seebohm, N., Henrion, U., Ureche, O.N., Seebohm, G., and Lang, U.E., Psychopharmacology, 2008, vol. 199, no. 1, pp. 47–54.
Fedorenko, O., Tang, C., Sopjani, M., Foller, M., Gehring, E.M., Strutz-Seebohm, N., Ureche, O.N., Lang, F., Seebohm, G., Ivanova, S., Semke, A., and Lang, U.E., Psychopharmacology, 2009, vol. 206, no. 3, pp. 429–435.
Ivanova, S.A., Fedorenko, O.Yu., Smirnova, L.P., and Semke, A.V., Sib. Vestn. Psykhitrii i Narkologii, 2013, no. 1, pp. 12–16.
Dunman, S.R. and Voleti, B., Trends Neurosci., 2013, vol. 35, no. 1, pp. 47–56.
Beaulieu, J.M., J. Psychiatry Neurosci., 2011, vol. 37, no. 1, pp. 9–16.
Rayasam, G.V., Tulasi, V.K., Sodhi, R., Davis, J.A., and Ray, A., Br. J. Pharmacol., 2009, vol. 156, no. 6, pp. 885–898.
Ivanova, S.A., Semke, V.Ya., Vetlugina, T.P., Rakitina, N.M., Kudyakova, T.A., and Simutkin, G.G., Neurosci. Behav. Physiol., 2007, vol. ò. 37, no. 5, pp. 527–530.
Klein, P.S. and Melton, D.A., Proc. Natl. Acad. Sci. USA, 1996, vol. 93, no. 16, pp. 8455–8459.
Li, X. and Jope, R.S., Neuropsychopharmacology, 2010, vol. 35, no. 11, pp. 2143–2154.
Li, X., Friedman, A.B., Roh, M.S., and Jope, R.S., J. Neurochem., 2005, vol. 92, no. 3, pp. 701–704.
Vetlugina, T.P., Ivanova, S.A., Semke, V.Ya., and Kornetov, N.A., Byull. Eksp. Biol. Med., 2000, vol. 129.
Gladkevich, A., Kauffman, H.F., and Korf, J., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2004, vol. 28, no. 3, pp. 559–576.
Freland, L. and Beaulieu, J.M., Front. Mol. Neurosci., 2012, vol. 5, pp. 9–15.
Natvig, D.B., Limfotsity: vydelenie, fraktsionirovanie, kharakteristika (Lymphocytes: Isolation, Fractionation and Characterization), Moscow: Bukinist, 1980.
Laemmli, U.K., Nature, 1970, vol. 227, pp. 680–685.
Merikangas, K.R. and Kalaydjian, A., Curr. Opin. Psychiatry, 2007, vol. 20, no. 4, pp. 353–358.
Simutkin, G.G., Obozrenie Psikhiatrii i Meditsinskoi Psikhologii im. V.M. Bekhtereva, 2010, no. 1, pp. 10–14.
Emamian, E.S., Birnbaum, M.J., Karayiorgou, M., and Gogos, J.A., Nat. Genet., 2004, vol. 36, no. 2, pp. 131–137.
Uzbekov, V.G., Misionzhnik, E.Y., Maximova, N.M., and Vertogradova, O.P., Hum. Psychopharmacol. Clin. Exp., vol. 21, pp. 109–115.
Manning, B.D. and Cantley, L.C., Cell, 2004, vol. 129, no. 7, pp. 1261–1247.
Belmaker, R.H. and Agam, A., N. Engl. J. Med., 2008, vol. 358, pp. 55–68.
Karege, F., Perroud, N., Burkhardt, S., Schwald, M., Ballmann, E., La Harpe, R., and Malafosse, A, Biol. Psychiatry, 2007, vol. 61, no. 2, pp. 240–245.
Li, X., Friedman, A.B., Zhu, W., Wang, L., Boswell, S., May, R.S., Davis, L.L., and Jope, R.S., Biol. Psychiatry, 2007, vol. 61, no. 2, pp. 216–222.
Pandey, G.N., Ren, X., Rizavi, H.S., and Dwivedi, Y., J. Psychiatr. Res., vol. 44, no. 3, pp. 143–148.
Polter, A.M., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C.A., Sweatt, J.D., McMahon, L., Bartolucci, A.A., Li, X., and Jope, R.S., Neuropsychopharmacology, 2010, vol. 35, no. 8, pp. 1761–1774.
Kozlovsky, N., Amar, S., Belmaker, R.H., and Agam, G., Int. J. Neuropsychopharmacol., 2006, vol. 9, no. 3, pp. 337–342.
Chen, G., Huang, L.D., Jiang, Y.M., and Manji, H.K., J. Neurochem, 1999, vol. 72, no. 3, pp. 1327–1330.
Dunlop, B.W. and Nemeroff, C.B., Arch. Gen. Psychiatry, 2007, vol. 64, no. 3, pp. 327–337.
Li, X., Zhu, W., Roh, M.S., Friedman, A.B., Rosborough, K., and Jope, R.S., Neuropsychopharmacology, 2004, vol. 29, no. 8, pp. 1426–1431.
Thornton, T.M., Pedraza-Alva, G., Deng, B., Wood, C.D., Aronshtam, A., Clements, J.L., Sabio, G., Davis, R.J., Matthews, D.E., Doble, B., and Rincon, M., Science, 2008, vol. 230, no. 5876, pp. 667–670.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.S. Losenkov, S.A. Ivanova, N.A. Vyalova, G.G. Simutkin, N.A. Bokhan, 2014, published in Neirokhimiya, 2014, Vol. 31, No. 3, pp. 240–245.
Rights and permissions
About this article
Cite this article
Losenkov, I.S., Ivanova, S.A., Vyalova, N.A. et al. Proteins of the Akt1/GSK-3β signaling pathway in peripheral blood mononuclear cells of patients with affective disorders. Neurochem. J. 8, 208–213 (2014). https://doi.org/10.1134/S1819712414030106
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712414030106